Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2008
03/19/2008EP1899325A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase
03/19/2008EP1899324A2 Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
03/19/2008EP1899323A2 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
03/19/2008EP1899322A1 Isoquinoline derivatives as inhibitors of rho-kinase
03/19/2008EP1899321A1 Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
03/19/2008EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM
03/19/2008EP1899319A2 Aminoquinoline and aminoquinazoline kinase modulators
03/19/2008EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
03/19/2008EP1899301A1 Novel 3-aza-spiroý5.5¨undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/19/2008EP1899296A1 Histamine-3 receptor antagonists
03/19/2008EP1899294A1 Therapeutic agents
03/19/2008EP1898917A1 Aminopyrimidines as kinase modulators
03/19/2008EP1898905A2 Hydroisoindoline tachykinin receptor antagonists
03/19/2008EP1646613B1 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
03/19/2008EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
03/19/2008EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists
03/19/2008EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects
03/19/2008EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors
03/19/2008EP1363630B1 Kappa opioid receptor ligands
03/19/2008EP1303496B9 Pyrimidine derivatives
03/19/2008EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/19/2008EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
03/19/2008CN101146806A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146797A 4-2-(cycloalkylamino)pyrimidin-4-YL!- (phenyl)- imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
03/19/2008CN101146795A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146794A Pyrazole derivatives for the inhibition of CDK and GSK
03/19/2008CN101146793A Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
03/19/2008CN101146792A Crystalline forms of a known pyrrolidine factor Xa inhibitor
03/19/2008CN101146791A 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors
03/19/2008CN101146790A 2-okso-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidiner anvendt som cgrp-antagonister
03/19/2008CN101146789A Chemical compounds
03/19/2008CN101146786A Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
03/19/2008CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases
03/19/2008CN101146530A 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension
03/19/2008CN101143862A Ionic compound containing chiral amine-thiourea (urea) and its preparation method and application
03/19/2008CN100375742C 4-oxoquinoline compounds and its use
03/18/2008US7345175 Biphenyl derivatives
03/18/2008US7345085 Indoles having anti-diabetic activity
03/18/2008US7345078 NF-κB inhibitors and uses thereof
03/18/2008US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
03/18/2008US7345068 Aromatic amino acid derivatives and medicinal compositions
03/18/2008US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes
03/18/2008US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity
03/18/2008US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels
03/18/2008US7345061 Alkylammonium salts of omeprazole and esomeprazole
03/18/2008US7345059 Diphenylpyridine derivatives, preparation and therapeutic application thereof
03/18/2008US7345057 5-HT7 receptor antagonists
03/18/2008US7345054 Heterocyclic inhibitors of ERK2 and uses thereof
03/18/2008US7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
03/18/2008US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders
03/18/2008US7345049 Phenylalanine derivatives
03/18/2008US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors
03/18/2008US7345045 Pyrido-pyrimidine compounds as medicaments
03/18/2008US7345041 Chemical compounds
03/18/2008CA2327784C Triazolones with a neuroprotective action
03/18/2008CA2315927C Oral pharmaceutical pulsed release dosage form
03/18/2008CA2287555C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
03/18/2008CA2287325C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
03/18/2008CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
03/18/2008CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators
03/13/2008WO2008030448A1 Phenethylamide derivatives with kinase inhibitory activity
03/13/2008WO2008030369A1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
03/13/2008WO2008030158A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
03/13/2008WO2008029924A1 Cyclic aminoalkylcarboxamide derivative
03/13/2008WO2008029825A1 Imidazole derivative
03/13/2008WO2008029217A2 Dipeptidyl peptidase iv inhibitors
03/13/2008WO2008029087A1 Chemical process
03/13/2008WO2008029084A1 Herbicidal compounds and compositions
03/13/2008WO2008028935A2 Pyridinyl-pyrimidine derivatives useful as potassium channel modulating agents
03/13/2008WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators
03/13/2008WO2008028690A1 1-(het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the ep2 receptor
03/13/2008WO2008028689A1 N-(1-phthalazin-1-ylpiperidin-4-yl)amides as ep2 receptor modulators
03/13/2008WO2008028624A1 Fungicides
03/13/2008WO2008028590A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
03/13/2008WO2008028427A1 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization
03/13/2008WO2008014252A3 Iap inhibitors
03/13/2008WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
03/13/2008WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists
03/13/2008WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors
03/13/2008WO2007139797A3 Method of preparing 4-halogenated quinoline intermediates
03/13/2008WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof
03/13/2008WO2007135527A3 Benzimidazolyl compounds
03/13/2008WO2007130820A3 Mglur5 modulators i
03/13/2008WO2007123400A9 Vaccine against nicotine addiction
03/13/2008WO2007092065A3 Compounds and compositions as lxr modulators
03/13/2008WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
03/13/2008US20080064878 Process for producing 1-pyridin-4-yl-indoles
03/13/2008US20080064876 For prevention/treatment of diseases related to tumor necrosis factors
03/13/2008US20080064874 2-Halofuryl/Thienyl-3-Carboxamides
03/13/2008US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes
03/13/2008US20080064729 Phenethylamide derivatives with kinase inhibitory activity
03/13/2008US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate
03/13/2008US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate
03/13/2008US20080064713 Dry Syrup Containing Loratadine
03/13/2008US20080064710 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
03/13/2008US20080064707 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
03/13/2008US20080064706 Piperidine Derivatives as Histamine H3 Receptor Ligands
03/13/2008US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors
03/13/2008US20080064703 Fused bicycloheterocycle substituted quinuclidine derivatives
1 ... 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 ... 1080